SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rolf Schoch who wrote ()6/18/1997 11:13:00 AM
From: r. peter Dale   of 4474
 
RESEARCH ALERT - Lehman starts four biotech stocks

NEW YORK, June 18 (Reuter) - Lehman Brothers said it initated coverage of four stocks in the biotechnology signal transduction sector.

-rated Ligand Pharmaceuticals Inc (LGND) a buy. Cadus Pharmaceutical Corp (KDUS) and ONYX Pharmaceuticals Inc (ONXX) were rated outperform.

-put a venture rating on Ariad Pharmaceuticals Inc (ARIA).

``We believe that understanding the pathways of the signaling process improves the pool of targets one maywish to direct highly specific, often orally available, and strongly potent drugs,'' a Lehman report said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext